Trial Profile
Phase IV.II Pilot Study of Treatment of Cytomegalovirus Infection With a Brief Induction With Ganciclovir i.v. Followed by Valganciclovir Oral in Solid Organ Transplant Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2011
Price :
$35
*
At a glance
- Drugs Ganciclovir (Primary) ; Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 04 Sep 2008 New trial record.